Breast cancer: how often does overdiagnosis occur?
02 March, 2022A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
New rare blood disease treatment on PBS
28 February, 2022Ultomiris (ravulizumab) will be listed for the first time for patients with paroxysmal nocturnal haemoglobinuria.
Liver cancer: non-invasive treatment trial to begin soon
25 February, 2022A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Global trial to investigate fractional COVID-19 boosters
23 February, 2022Up to 3300 healthy adults across Australia, Indonesia and Mongolia will be invited to take part in a global trial investigating the impact of administering reduced COVID-19 booster shots.
Music for stem cells: how soundwaves could help regrow bones
22 February, 2022Researchers have used soundwaves to turn stem cells into bone cells, in a tissue engineering advance that could help regrow bones.
Mechanical blood clot removal improves outcomes for stroke patients
21 February, 2022In an international study of 1000 stroke patients, nearly half of survivors achieved good to ideal outcomes at three months after the stroke if they had received mechanical clot removal.
Menopause: AIA, Aus Menopause Society partner to combat misdiagnoses
15 February, 2022AIA Australia believes that there is a significant need for increased education and access to evidence-based information about menopause to ensure correct diagnosis.
Immune stimulant could help prevent asthma in children
15 February, 2022A recent study by respiratory researchers from Perth has found that OM-85, an immune-boosting medication, could help prevent babies from developing asthma.
Scoping study for mRNA vaccine nasal spray begins
10 February, 2022Macquarie University respiratory scientist Professor Daniela Traini and Professor Pall Thordarson, Director of the UNSW RNA Institute, have started work on a scoping study to deliver mRNA vaccines via nasal spray.
New drug study hopes to help kids with severe epilepsy
10 February, 2022Researchers from the University of South Australia are working with European researchers to investigate a range of FDA-approved drugs with an aim to help kids with severe epilepsy.
New stillbirth prevention and bereavement care standard
07 February, 2022The Australian Commission on Safety and Quality in Health Care is seeking feedback on the draft Stillbirth Clinical Care Standard from clinicians, health services, consumers and anyone with an interest in maternity care, stillbirth or bereavement care.
Cervical screening tests could help detect ovarian, breast cancers
02 February, 2022Cervical screening tests could be used to find ovarian and breast cancers, according to international researchers.
Hospital Products Australia AGEMA Biosafety 2.0
01 February, 2022 | Supplied by: Hospital Products AustraliaThe AGEMA Biosafety 2.0 provides instant additional biocontainment wards or rooms for highly infectious diseases.
Combating resistance
31 January, 2022 by Amy SarcevicFor almost two years, the gaze of the public, healthcare system and media has been fixated on a very blatant public health threat; all the while a silent pandemic, antimicrobial resistance, has quietly continued gripping the world.
Emerging stronger
25 January, 2022From delivering over 500K vaccinations to disability and aged-care residents to achieving over five million completions for its online COVID-19 training platform for the Department of Health, global healthcare provider Aspen Medical has played a key role in Australia's pandemic response.
